This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Mihaly Gabli: Innovator in Drug Delivery Technology
Introduction
Mihaly Gabli is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of drug delivery technology, holding 2 patents that showcase his innovative approach to enhancing medical devices.
Latest Patents
One of Mihaly Gabli's latest patents is a sensor device designed for a drug delivery device. This sensor device includes an array of conducting elements, each forming part of a respective resonant circuit. These elements are operable to have a signal applied to them. The drug delivery device features a first movable element that supports a conductive region, which is configured to move along a path parallel to the device's longitudinal axis. When the sensor device is attached, the conducting elements are arranged so that each resonant circuit can output a signal indicative of the proximity of the conductive region to the respective conducting element. The sensor device also includes circuitry to receive these signals and determine information associated with the location along the path of the first movable element.
Career Highlights
Mihaly Gabli is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on improving drug delivery systems, which are crucial for effective patient treatment.
Collaborations
Mihaly has collaborated with several talented individuals in his field, including Thomas Klemm and Dmitri Bogatirsky. These collaborations have contributed to the advancement of technology in drug delivery systems.
Conclusion
Mihaly Gabli's work in the field of drug delivery technology exemplifies his commitment to innovation and improvement in medical devices. His patents reflect a deep understanding of the complexities involved in drug delivery systems, making him a valuable contributor to the industry.
